Effect of all-trans retinoic acid on telomerase activity in ovarian cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 2, 2004, Pages 309-316

  Purev, E ^a   Soprano, D R ^a   Soprano, K J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

All trans retinoic acid (ATRA); Ovarian cancer; Telomerase; Telomere

Indexed keywords

HTR PROTEIN; PROTEIN; RETINOIC ACID; RETINOL; RIBONUCLEOPROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOLECULAR CLOCK; NUTRIENT; OVARY CANCER; OVARY CANCER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; SOMATIC CELL; TELOMERE; VISION;

ANTINEOPLASTIC AGENTS; CATALYTIC DOMAIN; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; OVARIAN NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; RNA, UNTRANSLATED; TELOMERASE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 3242679756     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. De Luca L., Darwiche N., Jones C., Scita G.: Retinoids in differentiation and neoplasia. Scientific American 2-11, 1995.
2. Zhang D., Holmes W.F., Wu S., Soprano D. R., Soprano K. J.: Retinoids and ovarian cancer. J. Cell Physiol. 185:1-20, 2000.
3. Hong W.K., Endicott J., Itri L.M., Doos W., Batsakis J.G., Bell R., Fofonoff S., Byers R., Atkinson E.N., Vaughan C. et al.: 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315:1501-1505, 1986.
4. Holmes W.F., Soprano D.R., Soprano K.J.: Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a cd437-resistant ovarian carcinoma cell line. J. Biol. Chem. 277:45408-45419, 2002.
5. Soprano K.J., Soprano D.R.: Retinoic acid receptors and cancer. J. Nutr. 132:3809S-3813S, 2002.
6. Qin P., Cimildoro R., Kochhar D.M., Soprano K.J., Soprano D.R.: Pbx, meis, and igf-i are potential mediators of retinoic acid-induced proximodistal limb reduction defects. Teratology 66:224-234, 2002.
7. Wu S., Donigan A., Platsoucas C.D., Jung W., Soprano D.R., Soprano K.J.: All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late g1. Exp. Cell Res. 232:277-286, 1997.
8. Blackburn E.H.: Telomeres and telomerase. Keio J. Med. 49:59-65, 2000.
9. Cao Y., Li H., Deb S., Liu J.P.: Tert regulates cell survival independent of telomerase enzymatic activity. Oncogene 21:3130-3138, 2002.
10. McEachern M.J., Krauskopf A., Blackburn E.H.: Telomeres and their control. Annu. Rev. Genet. 34:331-358, 2000.
11. Blackburn E.H.: Telomere states and cell fates. Nature 408:53-56, 2000.
12. Chan S.W., Blackburn E.H.: New ways not to make ends meet: Telomerase, DNA damage proteins and heterochromatin. Oncogene 21:553-563, 2002.
13. Collins K., Mitchell J.R.: Telomerase in the human organism. Oncogene 21:564-579, 2002.
14. Leem S.H., Londono-Vallejo J.A., Kim J.H., Bui H., Tubacher E., Solomon G., Park J.E., Horikawa I., Kouprina N., Barrett J.C., Larionov V.: The human telomerase gene: Complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions. Oncogene 21:769-777, 2002.
15. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., Hahn W.C.: Telomerase maintains telomere structure in normal human cells. Cell 114:241-253, 2003.
16. Herbert B., Pitts A.E., Baker S.I., Hamilton S.E., Wright W.E., Shay J.W., Corey D.R.: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. U S A 96:14276-14281, 1999.
17. Xiang H., Wang J., Mao Y., Liu M., Reddy V N., Li D.W.: Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating rb/e2f pathway. Oncogene 21:3784-3791, 2002.
18. MacKenzie K.L., Franco S., Naiyer A.J., May C., Sadelain M., Rafii S., Moore M.A.: Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, sv40 t antigen and oncogenic n-ras. Oncogene 21:4200-4211, 2002.
19. Taggart A.K., Zakian V.A.: Telomerase: What are the est proteins doing? Curr. Opin. Cell Biol. 15:275-280, 2003.
20. Ulaner G.A., Hu J.F., Vu T.H., Giudice L.C., Hoffman A.R.: Telomerase activity in human development is regulated by human telomerase reverse transcriptase (htert) transcription and by alternate splicing of htert transcripts. Cancer Res. 58:4168-4172, 1998.
21. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., Arruda I., Robinson M.O.: A mammalian telomerase-associated protein. Science 275:973-977, 1997.
22. Masutomi K., Kaneko S., Yasukawa M., Arai K., Murakami S., Kobayashi K.: Identification of serum anti-human telomerase reverse transcriptase (htert) auto-antibodies during progression to hepatocellular carcinoma. Oncogene 21:5946-5950, 2002.
23. Delhommeau F., Thierry A., Feneux D., Lauret E., Leclercq E., Courtier M.H., Sainteny F., Vainchenker W., Bennaceur-Griscelli A.: Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative htert mutant. Oncogene 21:8262-8271, 2002.
24. Harley C.B.: Telomerase is not an oncogene. Oncogene 21:494-502, 2002.
25. Pendino F., Flexor M., Delhommeau F., Buet D., Lanotte M., Segal-Bendirdjian E.: Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc. Natl. Acad. Sci. U S A 98:6662-6667, 2001.
26. Wu S., Zhang D., Zhang Z.P., Soprano D.R., Soprano K.J.: Critical role of both retinoid nuclear receptors and retinoid-x-receptors in mediating growth inhibition of ovarian cancer cells by all- trans retinoic acid. Oncogene 17:2839-2849, 1998.
27. Wu S., Zhang Z.P., Zhang D., Soprano D.R., Soprano K.J.: Reduction of both rar and rxr levels is required to maximally alter sensitivity of ca-ov3 ovarian tumor cells to growth suppression by all- trans-retinoic acid. Exp. Cell Res. 237:118-126, 1997.
28. Liu W.J., Jiang J.F., Xiao D., Ding J.: Down-regulation of telomerase activity via protein phosphatase 2a activation in salvicine-induced human leukemia hl-60 cell apoptosis. Biochem. Pharmacol. 64:1677-1687, 2002.
29. Kishi S., Zhou X.Z., Ziv Y., Khoo C., Hill D.E., Shiloh Y., Lu K.P.: Telomeric protein pin2/trf1 as an important atm target in response to double strand DNA breaks. J. Biol. Chem. 276:29282-29291, 2001.
30. Zhou X.Z., Lu K.P.: The pin2/trf1-interacting protein pinx1 is a potent telomerase inhibitor. Cell 107:347-359, 2001.
31. Zhou X.Z., Perrem K., Lu K.P.: Role of pin2/trf1 in telomere maintenance and cell cycle control. J. Cell Biochem. 89:19-37, 2003.
32. Ding Z., Green A.G., Yang X., Chernenko G., Tang S.C., Pater A.: Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of htert: Correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model. Exp. Cell Res. 272:185-191, 2002.
33. Zhu X.D., Niedernhofer L., Kuster B., Mann M., Hoeijmakers J. H., de Lange T.: Ercc1/xpf removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 12:1489-1498, 2003.